Peripheral Nerve Block Adjuvants Dexmedetomidine Adhibition In Adductor Cannal and Sciatic Nerve Block:A Prospective,Randomized, Double-blinded,Controlled trail.

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16008192

Enrollment

Unknown

Registered

2016-03-31

Start date

2016-03-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Extremity Trauma Surgery

Interventions

ropivacaine group:0.4%ropivacaine

ropivacaine mixed with dexmedetomidine:0.4%ropivacaine mixed 1ug/kg dexmedetomidine

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 60 patients with American Society of Anesthesiologists (ASA) physical status I/II, 18~65 years, body mass index under 38 kg/m2 were scheduled for lower extremity surgery under adductor canal and sciatic nerve block were enrolled in this prospective, double-blind, controlled trial.

Exclusion criteria

Exclusion criteria: (1) Severe cardiovascular disease; (2) Significant renal or hepatic impairment; (3) History of drug and alcohol abuse; (4) Patients cannot cooperation; (5) Preoperative coagulation dysfunction; (6) Allergies to local anesthetics or dexmedetomidine; (7) Peripheral nerve injury or underlying injury.

Design outcomes

Primary

Measure	Time frame
Onset time of sensory block;Duration of sensory block;Onset time of motor block;Duration of motor block;	—

Countries

China

Contacts

Public ContactXue Jixiu

Xuanwu Hospital, Capital University

xuejixiu1@163.com+86 15699959630

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026